S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SNY

Sanofi (SNY)

Sanofi

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNY

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
11/18/2024	11:23AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
11/14/2024	11:59PM	GlobeNewswire Inc.	Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)	NASDAQ:SNY	Sanofi
11/06/2024	12:00AM	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis	NASDAQ:SNY	Sanofi
10/28/2024	4:56PM	PR Newswire (Canada)	L'immunisation par Beyfortus® pour protéger les nourrissons contre le VRS a commencé	NASDAQ:SNY	Sanofi
10/28/2024	4:54PM	PR Newswire (Canada)	Beyfortus® immunization to protect infants from RSV has begun	NASDAQ:SNY	Sanofi
10/25/2024	5:05AM	IH Market News	Capri Shares Crash 45% After Merger Block; Coursera Falls 18% on Lower Revenue Forecast	NASDAQ:SNY	Sanofi
10/21/2024	4:47AM	IH Market News	Spirit’s Stock Surges 56% on Refinancing; Starboard Invests in Kenvue; Cigna-Humana Merger Back in Negotiations	NASDAQ:SNY	Sanofi
10/17/2024	1:35AM	Business Wire	Sanofi and Orano Join Forces to Develop Next-generation Radioligand Medicines	NASDAQ:SNY	Sanofi
10/17/2024	1:35AM	Business Wire	Sanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle génération	NASDAQ:SNY	Sanofi
10/16/2024	11:26AM	PR Newswire (US)	FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals	NASDAQ:SNY	Sanofi
10/16/2024	5:00AM	PR Newswire (US)	Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies	NASDAQ:SNY	Sanofi
10/11/2024	5:31AM	IH Market News	BP Signals Rising Net Debt; Tesla Slumps; Stellantis CEO Announces Retirement; Berkshire Trims BofA Stake, and More	NASDAQ:SNY	Sanofi
09/27/2024	8:35AM	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD	NASDAQ:SNY	Sanofi
09/27/2024	6:00AM	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)	NASDAQ:SNY	Sanofi
09/24/2024	1:51PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
09/23/2024	5:32AM	IH Market News	Apollo Eyes $5 Billion Investment in Intel; TSMC and Samsung Explore UAE Chip Projects, and More	NASDAQ:SNY	Sanofi
09/20/2024	6:45AM	GlobeNewswire Inc.	Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old	NASDAQ:SNY	Sanofi
09/16/2024	7:00AM	PR Newswire (US)	Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new manufacturing line approved by FDA	NASDAQ:SNY	Sanofi
09/13/2024	11:15AM	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)	NASDAQ:SNY	Sanofi
09/12/2024	1:37AM	Business Wire	Accord de licence entre Sanofi, RadioMedix et Orano Med pour le développement d’une nouvelle génération de radiothérapies internes vectorisées contre les cancers rares	NASDAQ:SNY	Sanofi
09/12/2024	1:37AM	Business Wire	Sanofi, RadioMedix, and Orano Med Announce Licensing Agreement on Next-Generation Radioligand Medicine for Rare Cancers	NASDAQ:SNY	Sanofi
08/13/2024	8:06AM	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:SNY	Sanofi
08/13/2024	5:30AM	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SNY	Sanofi
08/13/2024	5:05AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
07/26/2024	11:08AM	PR Newswire (Canada)	Le vaccin FluzoneMD Haute Dose Quadrivalent demeure le vaccin préférentiellement recommandé pour protéger les adultes de 65 ans et plus contre la grippe	NASDAQ:SNY	Sanofi
07/26/2024	10:17AM	PR Newswire (Canada)	Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza	NASDAQ:SNY	Sanofi
07/25/2024	5:19AM	IH Market News	Earnings Updates: Ford Shares Fall 13% on EPS Miss, Stellantis Down 6%, Viking Therapeutics Up 20%, Unilever Up 5%	NASDAQ:SNY	Sanofi
07/10/2024	3:10PM	PR Newswire (US)	Sanofi ships U.S. influenza vaccines for the 2024/25 season	NASDAQ:SNY	Sanofi
07/09/2024	5:54AM	IH Market News	BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News	NASDAQ:SNY	Sanofi
06/26/2024	4:30PM	GlobeNewswire Inc.	Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine	NASDAQ:SNY	Sanofi

Showing the most relevant articles for your search:NASDAQ:SNY

1 2 3 4 5 6 7 8 9 10 Next >>

AMC Entertainment

Bioelectronics (PK)

Intergrated Cannabis Sol... (PK)

Kraig Biocraft Laborator... (QB)

Fannie Mae (QB)

Rennova Health (CE)

Digital Brand Media and ... (PK)

Lightwave Logic

North Bay Resources (PK)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions